Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. and its executives for alleged violations of the Securities Exchange Act of 1934, claiming misleading information regarding the company's revenue outlook and CEO's health concerns [1][4]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) and aims to represent purchasers or acquirers of C3.ai securities [1]. - Allegations include that C3.ai's executives created a false impression of reliable revenue projections while downplaying risks associated with CEO Thomas M. Siebel's health [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 FY 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, leading to a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff [6]. - The lead plaintiff is typically the investor with the greatest financial interest and acts on behalf of all class members [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [7].
TUESDAY INVESTOR DEADLINE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead the C3.ai Class Action Lawsuit - AI